Yes, osteoporosis can cause leg pain, but not directly. Bone loss itself is silent; leg pain arises when weakened bone fractures, when lost height and spinal changes alter how the legs and hips load, or when the medications used to treat osteoporosis cause bone or muscle pain. The symptom sits on top of a structural process, not inside it.
Osteoporosis is a skeletal disorder defined by reduced bone mineral density (BMD) and disrupted bone microarchitecture, which together raise fracture risk. The World Health Organization operationally defines osteoporosis as a T-score of −2.5 or lower on dual-energy X-ray absorptiometry (DXA). A T-score compares a person's BMD with that of a young adult reference population of the same sex. Because the threshold is a statistical cutoff rather than a pain threshold, a person can dip below it and feel nothing at all.
How loss of bone structure produces pain signals
Bone is living tissue, remodeled continuously by osteoclasts that resorb it and osteoblasts that rebuild it. In osteoporosis, resorption outpaces formation, so trabeculae thin, perforate, and disconnect, and cortical bone becomes porous. The structural damage weakens the bone's load-bearing capacity without activating the nociceptors, the sensory nerve endings that register pain. Bone pain signals arise mainly from the periosteum, the innervated membrane covering bone surfaces, and from the marrow and surrounding tissue. Intact but fenestrated trabeculae do not fire these fibers.
Pain enters the picture when the strained bone gives way. A fragility fracture is a fracture from a fall from standing height or less, or from no identifiable trauma at all. When a vertebral body collapses, the stance and gait adjust to protect the irritated bone, and altered pelvic and sacroiliac loading can refer into the hips, buttocks, and thighs. Vertebral wedging in the thoracic or lumbar spine can also reduce lumbar lordosis, and the consequent shift in leg biomechanics contributes to aching in the lower back and proximal legs. Strictly speaking, that is postural and mechanical pain, not a signal of a dissolving skeleton.
Nerve compression is a second mechanism, and a more direct one. Compression fractures can narrow the intervertebral foramina and pinch lumbar nerve roots. Pain then radiates down one leg in a dermatomal pattern with numbness, tingling, or weakness—sciatica from a fragile spine. Chronically shortened height and hyperkyphosis from multiple vertebral fractures compress the trunk and can produce rib and flank pain that overlaps with abdominal or hip pain.
The counterintuitive detail: the most common osteoporotic fracture in the legs does not stay in the leg. Roughly 70 to 75 percent of hip fractures occur in women. Hip fracture pain typically localizes to the groin, the outer hip, and the anterior thigh, and patients describe it as poorly localized. Because the femoral head and neck share the hip joint and the iliopsoas muscle, a fractured proximal femur can present as knee pain. Clinicians are taught that hip pathology refers to the knee, and in older adults with leg pain after a minor fall, that knee pain may be the most important red flag in the room.
The numbers behind the perception problem
Fragility fractures are common enough that leg pain in older adults deserves a low threshold for imaging. An estimated 1 in 2 women and 1 in 4 men over age 50 will sustain an osteoporotic fracture at some point. Hip fractures alone are projected to reach an estimated 6.3 million worldwide by 2050, and shoulder (proximal humerus) fractures are estimated at 1.2 million annually. These figures explain why a persistent thigh or groin pain in a postmenopausal woman should not be written off as arthritis.
About 20 percent of women and 33 percent of men who have an osteoporotic fracture die within 12 months. Mortality is not evenly distributed: proximal femur fractures carry the highest risk, reportedly 30 percent among those over 80 years old, versus roughly 10 to 15 percent for patients aged 50 to 80. A fractured vertebra, by contrast, carries an approximately 15 percent mortality risk, and some estimates reach 20 percent. The mortality figure is a reason for urgency, not a mechanism of pain.
Bone mineral density loses roughly 0.5 percent per year in the general population after about age 40, while a woman can lose an estimated 10 to 12 percent per year for a decade after menopause. The 1 percent of total bone mass lost each year before age 35 becomes a deficit because peak bone mass is never fully replaced after that point. In epidemiologic terms, a person who reaches a T-score of −2.5 can be far below the young-adult bone mass benchmark without ever having felt a symptom.
The largest pain source agrees with the smallest: among patients with a painful vertebral fracture, pain from the fracture site and referred pain from altered spinal loading are the dominant issues. Quantifying how much leg pain comes from osteoporosis versus osteoarthritis versus peripheral vascular disease is not possible from these numbers alone, because the numbers describe fracture incidence, not the origin of a given patient's pain.
When osteoporosis is not the cause
Most leg pain in adults over 50 is not a consequence of osteoporosis. Osteoarthritis of the knee and hip produces joint pain with stiffness, vascular claudication produces pain with walking that resolves with rest, and diastasis, tendinopathy, and radiculopathy from degenerative disc disease are all more common explanations. A spine with osteoporotic compression fractures may also have degenerative joint disease at the same segments; the two pathologies coexist and confound each other.
A second edge case is the person whose leg pain is caused by an osteoporosis medication rather than the disease. Bisphosphonates are associated with a rare adverse event called bisphosphonate-related atypical femoral fracture, and some patients on these agents develop new thigh or groin pain. Yearly zoledronic acid reduced the incidence of vertebral fractures by 70 percent and hip fractures by 22 percent in women with established osteoporosis. A third edge case is rarer and more dangerous: severe hypocalcemia during antiresorptive treatment can cause muscle cramps and tetany, often described as leg cramping. Treating those cramps as "just osteoporosis discomfort" delays recognition of an electrolyte problem.
A fourth edge case is primary hyperparathyroidism, which causes both bone loss and leg and muscle symptoms, and can masquerade as ordinary osteoporosis. The same applies to vitamin D deficiency with osteomalacia. In this context, the leg pain is from defective mineralization, not from low bone density, and it demands its own biochemical workup.
| Cause | Typical pain pattern | Key distinguishing clue | Initial test |
|---|---|---|---|
| Osteoporotic compression fracture | Sudden back pain, may radiate into flank, hip, or thigh | Pain after minor strain; height loss | Spine imaging |
| Hip fracture | Groin or anterior thigh pain; may present as knee pain | Fall from standing height; unable to bear weight | X-ray, then MRI |
| Atypical femoral fracture (bisphosphonates) | Thigh or groin pain, often prodromal | Long-term antiresorptive use; pain with weight bearing | Full-length femur X-ray |
| Lumbar radiculopathy | Dermatomal leg pain with numbness or weakness | Pain follows a nerve root distribution | MRI |
| Osteoarthritis | Joint-line pain, stiffness, worse with activity | Mechanical symptoms; normal strength | Clinical exam |
| Vascular claudication | Calf pain with walking, relieved by rest | Diminished pulses, skin changes | Ankle-brachial index |
| Hypocalcemia | Muscle cramps, tetany | Paresthesia, carpopedal spasm | Serum calcium, magnesium |
This table is a triage tool, not a diagnostic algorithm. Pain patterns overlap, and the person with two conditions can exhibit features of both.
Common misreadings of bone pain
Misconception one: osteoporosis is a painful disease. It is not, except through fracture, deformity, or medication effects. Professional groups describe osteoporosis as a silent disease because pain does not track with BMD. A T-score of −3.0 may be painless; a T-score of −2.0 with a fresh vertebral crush may be agony.
Misconception two: leg pain means bone density is dropping. Localized bone pain in the absence of fracture usually has a different explanation, such as a bone tumor, infection, or osteonecrosis. Persistent, night-waking, point-tender bone pain should not be attributed to osteoporosis until fracture and other bone pathology are excluded.
Misconception three: leg pain from osteoporosis is diagnostic of osteoporosis. It is not. Imaging findings such as cortical thinning or vertebral wedging can be incidental, and DXA remains the standard for diagnosis. A recurrent fragility fracture plus a DXA T-score of −2.5 or lower confirms osteoporosis with high fracture risk; a fragment of bone pain is not a substitute for BMD measurement.
Misconception four: the medications cause all the leg pain. Some do. Aromatase inhibitors and androgen deprivation therapy, used in breast and prostate cancer, accelerate bone loss and can cause musculoskeletal pain that includes the legs and joints. If a patient's leg pain started after starting an aromatase inhibitor, the temporal relationship matters, but determining causality requires clinical evaluation.
Practical steps and thresholds that matter
Get an imaging evaluation for any new, weight-bearing leg pain after a fall in someone over 50, especially if hip or groin pain is present, and especially with knee pain after a fall. Undisplaced hip fractures can be invisible on plain X-ray; MRI or CT is the next step. Delay increases the risk of displacement, which changes surgery and outcomes. Report new thigh or groin pain on antiresorptive therapy promptly. Pain that begins in the thigh and worsens with weight bearing warrants a full-length femur radiograph to rule out atypical femoral fracture. Use height change as a screening signal. A loss of 4 cm (about 1.5 inches) from peak height should prompt vertebral imaging and DXA if not recently done. Ask specifically whether the pain comes from the spine and radiates to the hips or legs. Have a DXA if you are a woman 65 or older, or a man 70 or older, or younger with risk factors. The diagnostic threshold is a T-score of −2.5 or lower; a T-score between −1.0 and −2.5 defines low bone mass, not osteoporosis. These thresholds are US-derived and reconcile with WHO categories. Do not treat leg pain as a reason to start or stop a drug. Stopping a bisphosphonate requires a physician because of the fracture rebound risk. The decision balances atypical femoral fracture risk against the far larger hip and vertebral fracture risk. Watch for warning signs that change the urgency: Sudden severe back pain in an older adult, especially with new height loss. New inability to bear weight after a fall. Thigh or groin pain in a long-term antiresorptive user. Leg weakness, numbness, or bowel and bladder changes. Fever, night sweats, or unintentional weight loss with bone pain.
Timeline and the limits of what the evidence shows
| Time after the event | What changes | What pain does |
|---|---|---|
| Bone loss before a fracture | Silent BMD decline; microarchitectural damage | No pain until fracture or deformity |
| Moment of fracture | Cortical break, periosteal irritation | Acute pain at fracture site, often referred |
| First weeks | Hematoma resorption, callus formation | Pain with movement; splinting of the spine |
| 2 to 3 months | Callus consolidates | Pain subsides; deformity remains |
| Months to years | Vertebral wedging and height loss accumulate | Recurrent or radiating pain; altered stance |
| After antiresorptive years | Suppressed remodeling | Rare atypical femoral prodromal pain in long-term users |
The limitations are real and should be stated plainly. The relationship between simple bone loss and leg pain has no validated, quantitative severity threshold, and no large diagnostic-accuracy study supports leg pain itself as a screen for osteoporosis. The specific incidence of atypical femoral fracture per year of bisphosphonate use, and the exact confidence of the reported hip fracture incidence, are not reliable to state without a specific surveillance dataset; those estimates vary by cohort, duration, and definition. A user should treat those numbers as approximate, and should rely on annual or biennial reassessment rather than a fixed cutoff derived from a single study. Beyond osteoporosis, primary hyperparathyroidism, osteomalacia, metabolic bone disease, and malignancy can all cause persistent bone pain that mimics it; those causes warrant referral rather than a symptom-based diagnosis. What the evidence supports is the opposite emphasis: diagnosis is a bone density measurement, pain is an alarm that should prompt imaging, and the absence of pain is not evidence of a healthy skeleton.